Description
An inhibitor of CBP/EP300 bromodomains (IC50s = 30 and 51 nM in a TR-FRET assay); selective for CBP and EP300 over the BET family of bromodomains (IC50s = >10 μM); is active at bromodomain BRD9 (IC50 = 0.73 μM); inhibits CBP (IC50 = 0.3 μM in a BRET assay) and inhibits MYC expression (EC50 = 0.6 μM) in AMO-1 cells
Formal name: (4R)-1,3,4,5-tetrahydro-4-methyl-6-[1-methyl-3-(1-methyl-1H-pyrazol-4-yl)-1H-indazol-5-yl]-2H-1,5-benzodiazepin-2-one
Synonyms:
Molecular weight: 386.5
CAS: 1884712-47-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Chromatin Reader Interactions||Research Area